Evidence map›Paper›PMID 27376136›Full record

ReviewBladder cancer (Amsterdam, Netherlands)2016

Pursuing Quality in the Application of Bladder Cancer Quality of Life Research.

N E Mohamed, F Gilbert, C T Lee, J Sfakianos, C Knauer, R Mehrazin, H Badr, D Wittmann, T Downs, D Berry and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Bladder cancer (Amsterdam, Netherlands), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  15. Article
  16. Article
  17. Basic issues concerning health-related quality of life.Central European journal of urology · 2017
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

N E MohamedDepartment of Urology, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
F GilbertUnaffiliated.
C T LeeDepartment of Urology, University of Michigan , Ann Arbor, MI, USA.
J SfakianosDepartment of Urology, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
C KnauerDepartment of Urology, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
R MehrazinDepartment of Urology, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
H BadrDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
D WittmannUnaffiliated.
T DownsDepartment of Urology, University of Wisconsin , Madison, WI, USA.
D BerryDana-Farber Cancer Institute , Boston, MA, USA.
B GivenDepartment of Medicine, Harvard Medical School, Dana-Farber Cancer Institute , Boston, MA, USA.
P WiklundDepartment of Urology, Icahn School of Medicine at Mount Sinai , New York, NY, USA.
G SteineckDivision of Clinical Cancer Epidemiology, Sahlgrenska universitetssjukhuset , Göteborg, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patient-reported outcomes (PRO), including health-related quality of life (HRQOL) measures, represent important means for evaluating patients' health outcomes and for guiding health care decisions made by patients, practitioners, investigators, and policy makers. In spite of the large number of studies examining HRQOL in patients with bladder cancer, very few review articles investigated this topic. Because these review studies report mixed results, incorporating bladder cancer HRQOL measures into standard urological practice is not a viable option. In this non-systematic review of the literature and commentary we note some general concerns regarding PRO research, but our primary focus is on the HRQOL methodology within the context of two types of bladder cancer: muscle invasive and non-muscle invasive bladder cancer. Considering bladder cancer HRQOL as the interaction of four areas of the assessment process (i.e., what model of HRQOL to choose, what instruments are available to fit the choice, how interpretation of the resulting data fits the model, and how to derive some utility from the chosen model) and the two types of disease (i.e., muscle invasive and non-muscle invasive) may move us toward a better understanding of bladder cancer HRQOL. Establishing a useful model of perceived general health or specific symptoms is the first and most important step in developing the responsive bladder cancer HRQOL measures necessitated by clinical settings.

Indexed as

bladder cancerconceptual model of quality of lifedesign and development of bladder cancer quality of life measureshealth-related quality of lifemuscle invasive bladder cancernon-muscle invasive bladder cancerPatient-reported outcomesquality of life assessments

Identifiers

PMID27376136
PMCPMC4927895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.